DiagnostykaFRA:7JS +1.17%16 Pretax Margin % is 16.11% as of Mar. 2026, which is 8% above its 10-year median of 14.93. GuruFocus rates FRA:7JS with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 203 Medical Diagnostics & Research companies, Diagnostyka ranks better than 79.31% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Diagnostyka's Pre-Tax Income for the
three
months ended in Mar. 2026 was €25.0 Mil. Diagnostyka's Revenue for the
three
months ended in Mar. 2026 was €155.2 Mil. Therefore, Diagnostyka's pretax margin for the quarter that ended in Mar. 2026 was 16.11%.
The historical rank and industry rank for Diagnostyka's Pretax Margin % or its related term are showing as below:
FRA:7JS'
s Pretax Margin % Range Over the Past 10 Years
Min: 10.93 Med: 14.93 Max: 37.98
Current: 13.17
FRA:7JS's Pretax Margin % is ranked better than 79.31% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.56
vs FRA:7JS: 13.17
Diagnostyka (FRA:7JS) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Diagnostyka Pretax Margin % Related Terms
Diagnostyka Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Diagnostyka's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7JS vs TMO, DHR, IDXX: Pretax Margin % Comparison
For the Diagnostics & Research subindustry, Diagnostyka's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostyka Pretax Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Diagnostyka's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Diagnostyka's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostyka (FRA:7JS) has a Pretax Margin % of 16.11% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Diagnostyka and its competitors. This is near median its historical median of 14.93. Over the past decade, Diagnostyka's Pretax Margin % has ranged from 10.93 to 37.98. According to the industry distribution chart, Diagnostyka ranks #42 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 20.7%.
Is Diagnostyka's Pretax Margin % too high?
Diagnostyka's current Pretax Margin % of 16.11% is near median its 10-year median of 14.93. Over the past 10 years, this metric has ranged from a low of 10.93 to a high of 37.98. Based on the distribution chart, Diagnostyka ranks #42 out of 203 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Diagnostyka has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Diagnostyka's Pretax Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Diagnostyka ranks #42 out of 203 companies for Pretax Margin %. This places Diagnostyka in the top 21% of its industry — outperforming the majority of peers. Historically, Diagnostyka's own Pretax Margin % has ranged from 10.93 to 37.98 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Diagnostyka and its competitors. Diagnostyka's current Pretax Margin % is 16.11%, which is near median its own 10-year median of 14.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostyka stock overvalued right now?
Diagnostyka (FRA:7JS) has a current Pretax Margin % of 16.11%. The current Pretax Margin % is 16.11%, which is near median its 10-year median of 14.93. Diagnostyka's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Diagnostyka (FRA:7JS), the current Pretax Margin % is 16.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.
16GF Score
Get the complete analysis for FRA:7JS
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7JS has been successfully added to your 
